Daiichi Sankyo and UCSF have established a drug-discovery collaboration focused on developing novel therapeutics and molecular diagnostics for multiple neurodegenerative diseases.
April 03, 2014
March 31, 2014
Young adults with such cardiac risk factors as high blood pressure and elevated glucose levels have significantly worse cognitive function in middle age, according to a new study by dementia researchers at UCSF.
March 20, 2014
Researchers are recording brain activity in visually stunning ways that could lead to targeted therapies for Alzheimer’s, autism and other diseases.
March 13, 2014
New research by UC San Francisco neuroscientists suggests that the body may get help in fast-changing situations from a specialized brain circuit that causes visual system neurons to fire more strongly during locomotion.
March 05, 2014
UCSF neuroscientist Adam Gazzaley, MD, PhD, is hoping to paint a fuller picture of what is happening in the minds and bodies of those suffering from brain disease with his new lab, Neuroscape, which bridges the worlds of neuroscience and high-tech.
February 03, 2014
A new study led by researchers from UCSF Benioff Children’s Hospital is the first to evaluate whether purified cannabinoid is effective in treating severe forms of childhood epilepsy.
January 30, 2014
UCSF researchers are reporting a detailed account of how speech sounds are identified by the human brain. The finding offers unprecedented insight into the basis of human language and may shed light on language disorders, including dyslexia.
January 17, 2014
Joseph DeRisi, PhD, and Allison Doupe, MD, PhD were honored by the National Academy of Sciences for their “extraordinary scientific achievements” yesterday. They join 13 others in the fields of physical, biological and social sciences.
January 09, 2014
Scientists have discovered a type of RNA that could have enormous potential for better diagnosing and treating many types of cancer, Alzheimer's, multiple sclerosis and other diseases.
January 07, 2014
Scientists at the UCSF-affiliated Gladstone Institutes have discovered how the interplay between two proteins in the brain fuels the degradation and death of the class of brain cells, or neurons, that leads to Parkinson’s.